ANSM : Agence nationale de sécurité du médicament et des produits de santé
Glossaire
|
Abonnement
|
Agenda
|
Newsletter
Produits de santé
L'ANSM
S'informer
Décisions
Activités
Dossiers
Publications
Services
Déclarer un effet indésirable
Recherche:
Date de publication
X
Plus d'un an
Rubrique
X
- Information in English
Résultats de votre recherche
167 résultats pour la recherche
Trier par:
Pertinence
-
Date
Situation update of the controls regarding the Poly Implant Prothèse Company performed by the health authorities – Executive summary
(18/10/2012)
Compatibility between medical devices
(19/05/2008)
PIP Breast Implants Situation update -Report
(11/06/2013)
Evaluation of the risk of transmission of Creutzfeldt-Jakob agent by blood and its constituents
(03/06/2008)
2004 - Annual Haemovigilance report - Abstract
(24/03/2009)
2002 - Annual Haemovigilance report
(24/03/2009)
2001 - Annual Haemovigilance report
(24/03/2009)
2008 - Annual Haemovigilance report
(04/01/2010)
2009 - Annual Haemovigilance report
(12/04/2011)
2009 - Annual Haemovigilance report - Abstract
(12/04/2011)
Investigation of Grade ≥ 2 allergic Recipient Adverse Reactions (RAEs)
(18/06/2012)
Analysis of the risk of transmission of variant of creutzfeldt-jakob disease by health products and by tissues and fluids of human origin - Update of findings of ad hoc group report of december 2000
(03/06/2008)
Analysis of the risk of transmission of the variant creutzfeldt-jakob disease by medicinal products of human origin and labile blood products: Data update of the ad hoc group reportdated december 2000
(03/06/2008)
Analysis of the risk of transmission of the variant Creutzfeldt-Jakob Disease by medicinal products of human origin and labile blood products : Data update of the ad hoc group report dated December 2000
(03/06/2008)
Market surveillance 2005-2006 of screening and assay reagents for total antibodies directed against the hepatitis A virus (HAV) - Abstract
(01/04/2008)
Market surveillance - Estradiol assays - Abstract
(01/04/2008)
Market surveillance 2004- 2005 of instruction for use of growth hormone (GH) in vitro diagnostic medical devices - Abstract
(01/04/2008)
HbA1c reagents : Instructions for use /guidelines - Abstract
(01/04/2008)
Market surveillance 2005-2006 of instruction for use of Cortisol in vitro diagnostic medical devices - Abstract
(01/04/2008)
Market Control 2004-2006 of screening and quantification devices for anti-HBs antibodies - Abstract
(01/04/2008)
1
2
3
4
5
6
7
8
9
2017 - droit d'auteur ANSM
Ressources humaines
|
Marchés publics
|
Portail des agences sanitaires
|
Mentions légales
|
Plan du site
|
Contacts